These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 22133996)

  • 41. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
    Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y;
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Continuous arterial infusion of low-dose cisplatin, 5-fluorouracil as adjuvant therapy in cytoreductive surgery for advanced hepatocellular carcinoma].
    Ogata T; Okuda K; Tanaka S; Shibata J; Koga A; Kinoshita H; Nakayama T; Aoyagi S; Tanaka M; Tanikawa K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1661-4. PubMed ID: 9382501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
    Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A long-term survival case of hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombi].
    Hashimoto Y; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2693-5. PubMed ID: 21224682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma].
    Kohnoe S; Taketomi A; Morita M; Baba H; Matsuoka H; Seo Y; Saito T; Tomoda H
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1429-32. PubMed ID: 8854771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)].
    Takayama W; Asano T; Kobayashi S; Nakagouri S; Kenmochi T; Okazumi S; Takeda A; Fukunaga T; Iwasaki K; Shutou K; Matsuzaki H; Aoyama H; Shinotou K; Kouno T; Isono K
    Gan To Kagaku Ryoho; 1998 May; 25(6):867-71. PubMed ID: 9617325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical study of continuous local arterial-infusion chemotherapy for severely advanced hepatocellular carcinoma (HCC) using reservoir].
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Suga T; Itobayashi E; Shimauchi A
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1769-74. PubMed ID: 8397488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
    Okita K; Yamasaki T; Hamabe S; Saeki I; Harima Y; Terai S; Sakaida I
    Hepatogastroenterology; 2012; 59(114):533-7. PubMed ID: 22353519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
    Ikeda M; Okusaka T; Ueno H; Takezako Y; Morizane C
    Cancer; 2005 Feb; 103(4):756-62. PubMed ID: 15637692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
    Prévost A; Mérol JC; Aimé P; Moutel K; Roger-Liautaud F; Nasca S; Legros M; Coninx P
    Oncol Rep; 2005 Sep; 14(3):771-6. PubMed ID: 16077990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The study of continuous arterial infusion chemotherapy with 5-FU and CDDP in patients with hepatocellular carcinoma].
    Yanagi I; Koga A; Aso K; Shirotani T; Komesu I; Okuda K; Ohgami N; Sou H; Shibata J; Kumabe T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2207-10. PubMed ID: 7944441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
    Uka K; Aikata H; Takaki S; Miki D; Jeong SC; Hiramatsu A; Kodama H; Shirakawa H; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K
    Liver Int; 2007 Nov; 27(9):1209-16. PubMed ID: 17919232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion.
    Imura S; Ikemoto T; Morine Y; Fujii M; Miyake H; Tashiro S; Shimada M
    Hepatogastroenterology; 2008; 55(82-83):615-20. PubMed ID: 18613419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
    Kasai K; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Kuroda H; Takikawa Y; Suzuki K
    Cancer; 2012 Jul; 118(13):3302-10. PubMed ID: 22072099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
    Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma].
    Yanagi I; Koga A; Okuda K; Nishio T; Shibata J; Aso K; Matuo H; Nagashima J; So H; Nakayama T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1419-21. PubMed ID: 8854768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma.
    Urabe T; Kaneko S; Matsushita E; Unoura M; Kobayashi K
    Oncology; 1998; 55(1):39-47. PubMed ID: 9428374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.
    Poggi G; Montagna B; Melchiorre F; Quaretti P; Delmonte A; Riccardi A; Tagliaferri B; Sottotetti F; Di Cesare P; Stella MG; Villani L; Zorzetto M; Greco G; Cornalba G; Bernardo G
    Anticancer Res; 2011 Nov; 31(11):3927-33. PubMed ID: 22110221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus.
    Wu J; Huang WJ; Wang HY; Wang YF; Peng BG; Zhou Q
    Med Oncol; 2015 Mar; 32(3):65. PubMed ID: 25691293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.